Skip to main content

Open Access 28.03.2024 | Review Article

Definitions of hospital-acquired pneumonia in trauma research: a systematic review

verfasst von: Tim Kobes, Diederik P. J. Smeeing, Falco Hietbrink, Kim E. M. Benders, R. Marijn Houwert, Mark P. C. M. van Baal

Erschienen in: European Journal of Trauma and Emergency Surgery

Abstract

Purpose

What are reported definitions of HAP in trauma patient research?

Methods

A systematic review was performed using the PubMed/MEDLINE database. We included all English, Dutch, and German original research papers in adult trauma patients reporting diagnostic criteria for hospital-acquired pneumonia diagnosis. The risk of bias was assessed using the MINORS criteria.

Results

Forty-six out of 5749 non-duplicate studies were included. Forty-seven unique criteria were reported and divided into five categories: clinical, laboratory, microbiological, radiologic, and miscellaneous. Eighteen studies used 33 unique guideline criteria; 28 studies used 36 unique non-guideline criteria.

Conclusion

Clinical criteria for diagnosing HAP—both guideline and non-guideline—are widespread with no clear consensus, leading to restrictions in adequately comparing the available literature on HAP in trauma patients. Studies should at least report how a diagnosis was made, but preferably, they would use pre-defined guideline criteria for pneumonia diagnosis in a research setting. Ideally, one internationally accepted set of criteria is used to diagnose hospital-acquired pneumonia.

Level of evidence

Level III.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1007/​s00068-024-02509-8.
Prior abstract publication/presentation: Poster presentation at the 2022 European Congress of Trauma and Emergency Surgery in Oslo, Norway.
Abkürzungen
ATS
American Thoracic Society
BSAC
British Society for Antimicrobial Chemotherapy
CDC
Centers for Disease Control and Prevention
ECDC
European Center for Disease Prevention and Control
HAP
Hospital-acquired pneumonia
IDSA
Infectious Disease Society of America
SIR
Swedish Intensive Care Registry
VAP
Ventilator-associated pneumonia

Background

Nosocomial pneumonia is among the most frequent complications in trauma patients and is associated with increased mortality and poor prognosis [13]. The incidence of nosocomial pneumonia ranges from 4.3 to 38.3% in the literature, and this wide variety may cast doubt on the individual studies’ comparability [4, 5].
Several types of nosocomial pneumonia have been described in the literature [6]. Most guidelines on nosocomial pneumonia create a distinction between hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) [79]. Although VAP essentially is a particular type of HAP, the etiology is not the same. In VAP, endotracheal intubation enables upper respiratory tract colonization by inserting a foreign body; therefore, the two pneumonia types should not be considered equivalent [10]. Nonetheless, the diagnostic criteria are similar for HAP and VAP in most guidelines, though they differ in the exact duration of mechanical ventilation and the time between mechanical ventilation and pneumonia onset to distinguish VAP from HAP [79].
To diagnose hospital-acquired pneumonia, microbiologic diagnostics are superior to clinical symptoms or radiologic examination [10]. Collecting sputum or tracheal secretions has high sensitivity but low specificity, while bronchoalveolar lavage and comparable methods have both high sensitivity and specificity. However, as fluid is introduced into the lungs, bronchoalveolar lavage is generally unsuitable for non-mechanically ventilated patients and is, therefore, mainly used to diagnose VAP [11]. Thus, HAP diagnosis is reliant on clinical criteria.
The combination of varying incidence and diagnostic criteria reliance raises the question of what criteria have been previously used to diagnose HAP in trauma patient research [12, 13]. Potentially, HAP incidence varies because of the use of different diagnostic criteria. Therefore, this systematic review was conducted to create an overview of reported definitions of hospital-acquired pneumonia in trauma research.

Methods

This systematic review was performed according to the Preferred Reporting Items for Systematic research and Meta-Analysis (PRISMA) checklist and registered on PROSPERO (review identification number CRD42022350131) [14].

Search strategy and execution

A literature search was performed in PubMed/MEDLINE. The search syntax was constructed to identify studies that stated a definition for pneumonia (Supplemental Table 1) from initiation to September 2019. The search syntax included the following: the MeSH terms and subheadings “Wounds and Injuries,” “Injuries,” “Pneumonia,” “Incidence,” “Prevalence,” “Risk Factors,” and “Prevention and Control”; keywords derived from the MeSH terms and subheadings; and additional keywords on trauma patients, clinical criteria, definitions, prediction, and prophylaxis. Animal studies were excluded from the syntax.

Review process

The search results were imported into Rayyan for processing [15]. Rayyan is a free online tool that helps researchers conduct systematic reviews. Studies in trauma patients with a reported definition of HAP were included, with no limitations set on the type of trauma. We excluded certain study populations (pediatric, burns, (near-)drowning, non-traumatic fractures, postmortem), other entities of pneumonia or pulmonary complications (solely as an outcome or mixed with HAP), non-original research papers, and studies in a language other than English, Dutch, or German. We assumed that all Intensive Care Unit admitted patients were at risk for VAP unless stated differently. Subsequently, we excluded studies that did not use clinical criteria to diagnose HAP but presented references to these studies separately in Supplemental Table 2.
One reviewer (TK) assessed the in- and exclusion stepwise: first, the patient population; second, the pneumonia outcome; and lastly, other remaining criteria. The same reviewer assessed the methodological quality using the MINORS criteria: a clarification of used criteria can be found in Supplemental Table 3 [16]. The possible score on the MINORS criteria ranges from 0 (lowest) to 24 (highest) for comparative studies. In non-comparative studies, 16 is the highest possible score. Any borderline cases were discussed with a second reviewer (DS) before definitive in-/exclusion or quality scoring.
For each study, the following data were obtained: first author, year of publication, study period, study design, cohort size, and the applied diagnostic criteria. All data extraction was conducted by one reviewer (TK).

Results

The PubMed/MEDLINE database search resulted in 5758 studies. One hundred and sixteen studies were eligible for the qualitative comparison; seventy studies (60%) did not use clinical criteria to diagnose HAP (e.g., medical records or ICD-codes; Supplemental Table 2). The remaining 46 studies were included in the qualitative analysis [12, 1764]. The study selection process is summarized in the PRISMA flowchart (Fig. 1). The included studies were performed retrospectively (21/46) and prospectively (25/46). Table 1 shows the baseline characteristics of the included studies.
Table 1
Baseline characteristics of included studies
Author
Year
Country
Study period
Design
Cohort size
Study quality§
Seok [19]
2019
Korea
2013–2018
Retrospective, observational, single-center study
207
14
Conradsson [20]
2019
South Africa
2013–2014
Prospective, population-based cohort study
139
14
Warren [18]
2019
United States
2014–2016
Quasi-experimental pretest–posttest evaluation plan
417
12
Wutzler [17]
2019
Germany
2010–2014
Retrospective, observational study
1,162
15
Djuric [23]
2018
Serbia
2014–2016
Prospective patient-based, single-center surveillance study
406
20
Guo [22]
2018
China
2010–2016
Randomized double‐blind, placebo‐controlled clinical trial
204
15
Yadollahi [21]
2018
Iran
2015–2017
Prospective cohort
10,553
11
Denis [24]
2018
Canada
2010–2015
Prospective cohort study
159
16
Folbert [26]
2017
The Netherlands
2011–2013
Naturalistic cohort study
452
14
Yoo [25]
2017
Korea
2010–2014
Prospectively compiled database was used to identify retrospective patients
272
17
Curtis [27]
2016
Australia
2014
Retrospective before-after cohort study
546
21
Ewan [61]
2015
England
2009–2010
Prospective study
90
9*
Yun [28]
2015
United States
2009–2010
Multicenter, observational cohort
423
9*
Kamiya [29]
2015
Japan
2009–2012
Retrospective comparative analysis using an historical cohort control
62
14
Landeen [30]
2014
United States
2005–2011
Retrospective observational study
364
18
Yang [12]
2014
United States
2003–2011
Single-center retrospective cohort study
619
15
Mica [32]
2013
Switzerland
1996–2007
Retrospective study
628
16
Hyllienmark [33]
2013
Sweden
2007–2011
Retrospective cohort study
322
12*
Schirmer-Mikalsen [31]
2013
Norway
2004–2009
Prospective study
133
14
Yeung [34]
2012
United States
2003–2010
Patient control study
162
22
Hakim [35]
2012
Egypt
2008–2011
Randomized, parallel-arm, open-label study
55
7*
Strumwasser [36]
2011
United States
2005–2010
Retrospective study
106
7*
Becher [23]
2011
United States
2008–2009
Retrospective study
116
12
Karunakar [24]
2010
United States
1997–2005
Retrospective review
110
16
Worrall [25]
2010
United States
Unknown period
Retrospective analysis
130
10
García-Alvarez [26]
2010
Spain
1998–2001
Prospective study
290
11
Friese [27]
2008
United States
2000–2003
Retrospective, observational cohort analysis
678
13
Schirmer-Mikalsen [28]
2007
Norway
1998–2002
Retrospective study
133
11
Giamberardino [29]
2007
Brazil
2000–2001
Retrospective study
416
9
Bochicchio [31]
2004
United States
1997–1999
Prospective study
182
11
Kamel [32]
2003
United States
1997–1999
Retrospective observational study
131
14
McKinley [33]
2002
United States
Unknown
2-year prospective data comparison
117
12
Carson [34]
1999
United States
1983–1993
Retrospective cohort study
9,598
12
Claxton [35]
1998
Canada
1981–1994
Retrospective study
72
14
Bozorgzadeh [36]
1999
United States
Unknown period
Prospective, randomized study
300
15
Gonzalez [37]
1998
United States
1992–1995
Double-blind randomized clinical trial
139
15
Allen [38]
1997
United States
Unknown 4-year period
Retrospective review
210
8
Morrison [39]
1996
United States
1989–1994
Retrospective cohort study
80
6*
Renz [40]
1995
United States
1988–1991
Prospective case series
254
8*
Nichols [41]
1994
United States
1988–1992
Double-blind, randomized clinical trial
119
19
Beraldo [42]
1993
Brazil
1989
Review study
664
4*
Rello [43]
1992
Spain
1988–1990
Prospective Study
161
14
Moore [44]
1989
United States
1984–1987
Prospective, randomized study
308
15
Moore [45]
1989
United States
1985–1987
Prospective, randomized study
59
13
LoCurto [46]
1986
United States
1984–1985
Prospective, randomized study
58
13
Grover [47]
1977
United States
Unknown
Double-blind prospective study
75
13
§The study quality was measured using the MINORS criteria; the potential score ranges from 0 (lowest) to 16 or 24 (highest)
*These studies could score a maximum of 16 points

Diagnostic criteria

Forty-eight unique criteria were described in the included studies. We divided the criteria into five main categories: clinical (pulmonary symptoms and vital signs), laboratory (e.g., C-reactive protein, leukocytes), microbiologic (cultures or pathology), radiologic (X-ray or computed tomography), and miscellaneous (prescribed antibiotics and diagnosis in the medical health record). Radiologic criteria were most commonly used in the included studies (45/46) [12, 1863]. Clinical, laboratory, and microbiologic criteria were applied in 72, 28, and 39 percent of the included studies, respectively. Miscellaneous criteria were present in eight studies: four studies with only non-guideline criteria [12, 28, 30, 61] and as an addition to guideline criteria in the other four other studies [26, 27, 45, 48].
Guideline criteria were used to diagnose HAP in 18 out of 46 studies (Table 2). The five guidelines that were used originated from the United States of America or Europe: the Centers for Disease Control and Prevention (CDC), the European Center for Disease Prevention and Control (ECDC), the American Thoracic Society/Infectious Disease Society of America (ATS/IDSA), the Swedish Intensive Care Registry (SIR), and the British Society for Antimicrobial Chemotherapy (BSAC). The CDC criteria were cited in 13 out of 18 studies, whereas the ATS/IDSA, ECDC, SIR, and BSAC guidelines were used in the remaining four studies. Two studies applied the criteria of two different guidelines: Djuric et al. used the CDC and ECDC guidelines, and Ewan et al. used the ATS and BSAC guidelines [23, 61]. In the studies that used guideline criteria, 33 unique criteria were observed. The remaining 28 out of 46 studies described 37 non-guideline criteria to diagnose HAP (Table 3).
Table 2
Pre-defined guideline criteria used to diagnose hospital-acquired pneumonia in trauma patient research
https://static-content.springer.com/image/art%3A10.1007%2Fs00068-024-02509-8/MediaObjects/68_2024_2509_Tab2_HTML.png
†: ≤ and < , and ≥ and > are used interchangeably in this table when body temperatures are corresponding between studies
*These studies used more than one guideline
Abbreviations: ATS, American Thoracic Society; BSAC, British Center for Antimicrobial Chemotherapy; CDC, Centers for Disease Control and Prevention; CRP, C-reactive protein; ECDC, European Center for Disease Prevention and Control; Rad., radiological; SIR, Swedish Intensive Care Registry; ↓, worsening
Table 3
Non-guideline criteria used to diagnose hospital-acquired pneumonia in trauma patient research
https://static-content.springer.com/image/art%3A10.1007%2Fs00068-024-02509-8/MediaObjects/68_2024_2509_Tab3_HTML.png
†: ≤ and < , and ≥ and > are used interchangeably in this table when body temperatures are corresponding between studies
Abbreviations: Misc miscellaneous, Rad radiological, SIRS systemic inflammatory response syndrome, worsening
A detailed overview of the used criteria in all included studies was added in Supplemental Table 4.

Methodological quality of included studies

The MINORS score for comparative studies ranged from 9 to 22 on a potential maximum score of 24. For non-comparative studies, the range was 4 to 9 out of 16. The minimum (9 vs. 4) and maximum scores (22 vs. 21) were not considerably different for studies with guideline and non-guideline criteria, respectively (Table 1; Supplemental Table 5).

Discussion

This systematic review provides a general overview of criteria utilized in trauma patient research to diagnose hospital-acquired pneumonia. In only 46 out of 5749 original studies, well-defined criteria were reported, either pre-defined by published guidelines or clear non-guideline criteria. Forty-eight unique criteria were presented and clustered into five categories: clinical, laboratory, microbiological, radiological, and miscellaneous.
In the 28 studies without pre-defined guideline criteria to diagnose HAP, 37 unique criteria were reported. The heterogeneity in the applied criteria can mainly be attributed to the vast diversity in clinical, laboratory, and microbiological thresholds. For example, when considering leukocyte count as an indicator of HAP, up to five different thresholds were reported, describing both an elevated and decreased leukocyte count as indicative of HAP. One could imagine that a lower cut-off point of leukocytosis (e.g., 10 × 109/L versus 13 × 109/L) may lead to a higher estimate of HAP cases in a research population. Similar threshold differences were observed for body temperature, including “fever” or “febrile” as subjective criteria.
Some studies cited established guidelines as a basis for diagnosis, but the authors added new criteria or deleted pre-defined criteria, thus introducing (potential) aggregate bias. For instance, four studies added “medical record documentation” or “start of antibiotic treatment” as a criterion to diagnose pneumonia in addition to guideline criteria [12, 28, 30, 61]. Also, several studies added specific criteria (e.g., hypothermia, worsening gas exchange, leukopenia, and bronchoalveolar lavage) to the ATS/IDSA criteria [12, 22, 34, 61, 64]. Though all are clinically relevant criteria, adjusting pre-defined criteria complicates the comparison of studies that use the same guidelines and increases bias.
Eighteen studies applied existing guideline criteria to diagnose HAP. However, five different guidelines were encountered, leading to a further decrease in uniformity. We encountered a similar variation in body temperature and leukocyte count cut-offs (Table 2) [79, 6567]. However, the number of variations was lower for the pre-defined guideline criteria: three versus five cut-offs for body temperature and leukocytosis. The 2015 ATS/IDSA guideline contained no distinct thresholds for hyperthermia and leukocytosis, resulting in differences between studies that used this guideline (Table 2) [67]. Despite the attempts to generate uniformity in diagnosing HAP by creating and using guideline criteria, the abovementioned differences make it difficult to compare the available literature completely. Only five studies diagnosed HAP based on the exact same criteria.
Guidelines are continuously updated based on new insights and available literature. The earliest CDC guideline dates from 1988, and the most recent from 2018. During these 30 years, the criteria for pneumonia diagnosis have changed substantially. For example, the 1988 CDC criteria for pneumonia diagnosis were clinical, radiologic, or microbiologic, while body temperature was not included as a criterion [68]. However, the 2018 guideline provides a more elaborate set of clinical, radiological, microbiological, and laboratory criteria [7]. As a result, it is more difficult to compare older data sets to more recent studies. Full implementation of or compliance with guideline criteria in clinical practice is hardly feasible for two reasons: patient care and study design. Study subjects are patients; therefore, clinical examination and experience remain decisive in starting pneumonia treatment. The authors understand that an inconclusive or negative X-ray should not delay antibiotic treatment, and awaiting a microbial culture is not mandatory or necessary in seriously ill patients. Using guideline criteria for pneumonia diagnosis in retrospective studies might be impracticable. Also, uniform diagnostic criteria for pneumonia are hard to accomplish in database or registry studies. Nonetheless, these limitations should be mentioned when encountered.
Previously, review studies have been issued on lacking definitions in trauma research, such as fracture-related infections and non-unions of long bones [6971]. To resolve a lack of definition, these review studies provide a basis for a consensus definition. Subsequently, Delphi method studies can be helpful in reaching consensus. Our study displays the wide variety of clinical criteria for HAP diagnosis in trauma research and exhibits how studies ought to be compared with caution. The comparison of results is essential in trauma patient research and for guidelines. Guideline issuers pursue workable and representable guidelines to help clinicians in decision-making. Continuous improvement is established with the results of clinical studies, for which comparability of results is necessary. Our results emphasize this importance. Though our study addressed a scientific problem rather than a clinical one, it can still impact day-to-day practice.
One established definition of HAP would improve the comparability of trauma research; expert consensus could be a solid foundation to start with. Given the complexity of trauma patients, any diagnostic definition should address potential issues and pitfalls to avoid overdiagnosis. Currently, hyperthermia is incorporated in all guidelines, and sputum and dyspnea (with or without worsening gas exchange) in all but one. Leukocytosis, a common marker for infection, is included in all guidelines. Microbiologic information and evidence of infection aid in diagnosis and treatment; the CDC and ECDC describe several types of respiratory cultures. Radiologic evidence of pneumonia—either radiographic or CT imaging—also supports a diagnosis. Expert consensus should incorporate these criteria. Nonetheless, hypo- or hyperthermia, dyspnea, and leukocytosis are also signs of the systemic inflammatory response syndrome, commonly observed in trauma patients and potentially complicating the diagnostic process [72]. Also, posttraumatic fever may have a non-infectious origin, such as neurogenic fever, and trauma is associated with an increased immune response, adding to the need for a dedicated leukocytosis threshold [73, 74]. Lastly, sputum can result from (severe) pulmonary contusion, though unlikely to be purulent [75]. We propose that a decision-making algorithm includes hyperthermia (≥ 38.5 ℃) and leukocytosis (> 12 × 109/L) as major criteria, in addition to microbiologic and radiologic evidence. Dyspnea and (purulent) sputum should be considered minor criteria. Our considerations and recommendations serve as a basis for expert consensus.
Some limitations of this study should be considered. Firstly, PubMed/MEDLINE was the only search engine used in this study, which could result in an incomplete overview of applied clinical criteria for HAP diagnosis. However, the wide variety of clinical criteria and the difficult comparison between studies are evident in the current number of included studies. Secondly, our overview of reported diagnostic criteria did not consider the recommended combinations of these criteria. Not doing so resulted in a more comprehensible overview of used criteria and did not diminish the conclusion of this study.

Conclusion

As few studies in trauma patient research report a clear, clinical definition of hospital-acquired pneumonia, results cannot be adequately compared. Moreover, the wide variety of non-guideline criteria and diversity in pre-defined guideline criteria do not facilitate proper comparison. Studies should at least report how a diagnosis was made, but preferably, they would use pre-defined guideline criteria for pneumonia diagnosis in a research setting. Ideally, one internationally accepted set of criteria is used to diagnose hospital-acquired pneumonia.

Declarations

Conflict of interest

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Orthopädie & Unfallchirurgie

Kombi-Abonnement

Mit e.Med Orthopädie & Unfallchirurgie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

Neuer Inhalt

Print-Titel

Anhänge

Supplementary Information

Below is the link to the electronic supplementary material.
Literatur
2.
Zurück zum Zitat Esnault P, Nguyen C, Bordes J, D’Aranda E, Montcriol A, Contargyris C, et al. Early-onset ventilator-associated pneumonia in patients with severe traumatic brain injury: incidence, risk factors, and consequences in cerebral oxygenation and outcome. Neurocrit Care. 2017;27(2):187–98. https://doi.org/10.1007/s12028-017-0397-4.CrossRefPubMed Esnault P, Nguyen C, Bordes J, D’Aranda E, Montcriol A, Contargyris C, et al. Early-onset ventilator-associated pneumonia in patients with severe traumatic brain injury: incidence, risk factors, and consequences in cerebral oxygenation and outcome. Neurocrit Care. 2017;27(2):187–98. https://​doi.​org/​10.​1007/​s12028-017-0397-4.CrossRefPubMed
4.
Zurück zum Zitat Andermahr J, Greb A, Hensler T, Helling HJ, Bouillon B, Sauerland S, et al. Pneumonia in multiple injured patients: a prospective controlled trial on early prediction using clinical and immunological parameters. Inflamm Res. 2002;51(5):265–72.CrossRefPubMed Andermahr J, Greb A, Hensler T, Helling HJ, Bouillon B, Sauerland S, et al. Pneumonia in multiple injured patients: a prospective controlled trial on early prediction using clinical and immunological parameters. Inflamm Res. 2002;51(5):265–72.CrossRefPubMed
8.
9.
Zurück zum Zitat European Center for Disease Prevention and Control (ECDC). Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals: full-scale survey and codebook. Stockholm: ECDC; 2012. European Center for Disease Prevention and Control (ECDC). Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals: full-scale survey and codebook. Stockholm: ECDC; 2012.
22.
Zurück zum Zitat Guo C, Lei M, Wang Y, Hua L, Xue S, Yu D, et al. Oral administration of probiotic Lactobacillus casei Shirota decreases pneumonia and increases pulmonary functions after single rib fracture: a randomized double-blind, placebo-controlled clinical trial. J Food Sci. 2018;83(8):2222–6. https://doi.org/10.1111/1750-3841.14220.CrossRefPubMed Guo C, Lei M, Wang Y, Hua L, Xue S, Yu D, et al. Oral administration of probiotic Lactobacillus casei Shirota decreases pneumonia and increases pulmonary functions after single rib fracture: a randomized double-blind, placebo-controlled clinical trial. J Food Sci. 2018;83(8):2222–6. https://​doi.​org/​10.​1111/​1750-3841.​14220.CrossRefPubMed
46.
Zurück zum Zitat Gonzalez RP, Holevar MR. Role of prophylactic antibiotics for tube thoracostomy in chest trauma. Am Surg. 1998;64(7):617–20 (discussion 20-1).PubMed Gonzalez RP, Holevar MR. Role of prophylactic antibiotics for tube thoracostomy in chest trauma. Am Surg. 1998;64(7):617–20 (discussion 20-1).PubMed
53.
Zurück zum Zitat Moore FA, Moore EE, Ammons LA, McCroskey BL. Presumptive antibiotics for penetrating abdominal wounds. Surg Gynecol Obstet. 1989;169(2):99–103.PubMed Moore FA, Moore EE, Ammons LA, McCroskey BL. Presumptive antibiotics for penetrating abdominal wounds. Surg Gynecol Obstet. 1989;169(2):99–103.PubMed
55.
Zurück zum Zitat Grover FL, Richardson JD, Fewel JG, Arom KV, Webb GE, Trinkle JK. Prophylactic antibiotics in the treatment of penetrating chest wounds. A prospective double-blind study. J Thorac Cardiovasc Surg. 1977;74(4):528–36.CrossRefPubMed Grover FL, Richardson JD, Fewel JG, Arom KV, Webb GE, Trinkle JK. Prophylactic antibiotics in the treatment of penetrating chest wounds. A prospective double-blind study. J Thorac Cardiovasc Surg. 1977;74(4):528–36.CrossRefPubMed
56.
Zurück zum Zitat Allen GS, Cox CS Jr, Moore FA, Duke JH, Andrassy RJ. Pulmonary contusion: are children different? J Am Coll Surg. 1997;185(3):229–33.PubMed Allen GS, Cox CS Jr, Moore FA, Duke JH, Andrassy RJ. Pulmonary contusion: are children different? J Am Coll Surg. 1997;185(3):229–33.PubMed
66.
Zurück zum Zitat Masterton RG, Galloway A, French G, Street M, Armstrong J, Brown E, et al. Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother. 2008;62(1):5–34. https://doi.org/10.1093/jac/dkn162.CrossRefPubMed Masterton RG, Galloway A, French G, Street M, Armstrong J, Brown E, et al. Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother. 2008;62(1):5–34. https://​doi.​org/​10.​1093/​jac/​dkn162.CrossRefPubMed
72.
Zurück zum Zitat Chakraborty RK, Burns B. Systemic inflammatory response syndrome. Treasure Island (FL): StatPearls Publisher; 2022. Chakraborty RK, Burns B. Systemic inflammatory response syndrome. Treasure Island (FL): StatPearls Publisher; 2022.
75.
Zurück zum Zitat Ganie FA, Lone H, Lone GN, Wani ML, Singh S, Dar AM, et al. Lung contusion: a clinico-pathological entity with unpredictable clinical course. Bull Emerg Trauma. 2013;1(1):7–16.PubMedPubMedCentral Ganie FA, Lone H, Lone GN, Wani ML, Singh S, Dar AM, et al. Lung contusion: a clinico-pathological entity with unpredictable clinical course. Bull Emerg Trauma. 2013;1(1):7–16.PubMedPubMedCentral
Metadaten
Titel
Definitions of hospital-acquired pneumonia in trauma research: a systematic review
verfasst von
Tim Kobes
Diederik P. J. Smeeing
Falco Hietbrink
Kim E. M. Benders
R. Marijn Houwert
Mark P. C. M. van Baal
Publikationsdatum
28.03.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Trauma and Emergency Surgery
Print ISSN: 1863-9933
Elektronische ISSN: 1863-9941
DOI
https://doi.org/10.1007/s00068-024-02509-8

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.